Showing results (221-230 of 256) with videos related to

Sort By:
Pageof 26
Canadian Geriatrics Journal : CGJ|June 24, 2022
Enabling Healthy Aging to AVOID Frailty in Community Dwelling Older CanadiansJananee Rasiah, Jeanette C Prorok, Rheda Adekpedjou, et al.
Systematic Reviews|October 21, 2022
Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic reviewAndrew Beck, Navindra Persaud, Laure A Tessier, et al.
JAMA Network Open|November 4, 2024
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus StatementZachary Nelson, Abdullah Tarik Aslan, Nathan P Beahm, et al.
JAMA Network Open|July 31, 2023
Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus StatementEmily G McDonald, Gloria Aggrey, Abdullah Tarik Aslan, et al.
The Journal of Antimicrobial Chemotherapy|April 18, 2023
A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureusAndrew Henderson, Matthew P Cheng, Ka Lip Chew, et al.
The Journal of Nutrition|March 13, 2026
A Randomized Trial of Vitamin D Supplementation and COVID-19 Clinical Outcomes and Long COVID: The Vitamin D for COVID-19 TrialDavaasambuu Ganmaa, Kaitlyn A Cook, Polyna Khudyakov, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2026
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBaAnna L Goodman, Nicholas Easom, Dana Bielopolski, et al.
CJC Open|April 12, 2021
Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding FactorsTerry Lee, Alessandro Cau, Matthew Pellan Cheng, et al.
Open Forum Infectious Diseases|October 2, 2020
Real-world Time to Positivity of 2 Widely Used Commercial Blood Culture Systems in Patients With Severe Manifestations of Sepsis: An Analysis of the FABLED StudyGuillaume Butler-Laporte, Cedric P Yansouni, Katryn Paquette, et al.
Clinical Trials (London, England)|August 21, 2020
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L Houston, Patrick R Lawler, Ewan C Goligher, et al.
Pageof 26